Updated
Reviewed
Sep. 21, 2022

Appendix A: Key to Acronyms

Study and Trial Names

Acronym Name
ACTG AIDS Clinical Trials Group
ADVANCE Assessing Donor Variability And New Concepts in Eligibility
ARDENT ACTG A5257 trial
ARTEMIS Affordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial Infarction Study
ATLAS Antiretroviral Therapy as Long-Acting Suppression
D:A:D Data Collection on Adverse Events of Anti-HIV Drugs
ECHO Evidence for Contraceptive Options in HIV
ENCORE Evaluation of Novel Concepts in Optimization of antiRetroviral Efficacy
FLAIR First Long-Acting Injectable Regimen
FLAMINGO Dolutegravir Compared to Darunavir/Ritonavir, Each in Combination With Dual Nucleoside Reverse Transcriptase Inhibitors 
HPTN HIV Prevention Trials Network
NADIA Nucleosides And Darunavir/Dolutegravir In Africa
NAMSAL New Antiretroviral and Monitoring Strategies in HIV-infected Adults in Low-Income Countries
STaR Single-Tablet Regimen
START Strategic Timing of AntiRetroviral Treatment

Appendix A: Key to Acronyms

Study and Trial Names

Acronym Name
ACTG AIDS Clinical Trials Group
ADVANCE Assessing Donor Variability And New Concepts in Eligibility
ARDENT ACTG A5257 trial
ARTEMIS Affordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial Infarction Study
ATLAS Antiretroviral Therapy as Long-Acting Suppression
D:A:D Data Collection on Adverse Events of Anti-HIV Drugs
ECHO Evidence for Contraceptive Options in HIV
ENCORE Evaluation of Novel Concepts in Optimization of antiRetroviral Efficacy
FLAIR First Long-Acting Injectable Regimen
FLAMINGO Dolutegravir Compared to Darunavir/Ritonavir, Each in Combination With Dual Nucleoside Reverse Transcriptase Inhibitors 
HPTN HIV Prevention Trials Network
NADIA Nucleosides And Darunavir/Dolutegravir In Africa
NAMSAL New Antiretroviral and Monitoring Strategies in HIV-infected Adults in Low-Income Countries
STaR Single-Tablet Regimen
START Strategic Timing of AntiRetroviral Treatment

Download Guidelines